Compass Therapeutics, Inc. · BOATS:CMPX

Compass Therapeutics, Inc. financial statements

Compass Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY2019FY2018
Revenue0850.0K000000
Cost of revenue1.47M1.89M1.90M1.62M2.40M2.12M1.92M
Gross profit-1.47M850.0K-1.89M-1.90M-1.62M-2.40M-2.12M-1.92M
Research and development56.0M42.3M38.1M30.0M20.3M14.9M22.4M27.1M
Selling, general and administrative16.9M15.1M12.2M11.7M10.9M12.9M11.6M11.2M
Operating income-72.8M-56.6M-50.4M-41.7M-81.9M-27.8M-32.1K-34.1M-32.8K-38.3M
Depreciation and amortization276.0K589.0K699.0K782.0K600.0K2.40M2.10M1.92M
EBITDA-72.6M-56.0M-49.7M-40.9M-81.3M-25.4M-32.0M-36.4M
Interest expense0370.0K908.0K5.38K1.23M3.28K767.0K
Income before tax-66.5M-49.4M-42.5M-39.2M-82.2M-29.5M-34.7M-38.2M
Income tax0000032.0K91.0K103.0K
Net income-66.5M-49.4M-42.5M-39.2M-82.2M-29.5M-37.5K-34.7M-36.0K-38.3M
Earnings per share, basic-0.42-0.36-0.33-0.37-1.31-0.96-0.01-5.19-0.01-7.66
Earnings per share, diluted-1.31-0.96-0.01-5.19-0.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY2019FY2018
Cash and equivalents30.6M43.5M24.2M34.9M144.5M47.1M3.75K25.3M4.87K57.5M
Short-term investments178.3M83.2M128.2M151.7M0
Receivables320.0K
Current assets209.8M132.8M153.9M194.8M147.1M50.2M3.75K26.2M4.87K58.9M
Property, plant and equipment102.0K353.0K898.0K1.57M2.24M1.13M3.75M5.37M
Total assets219.6M140.4M156.9M199.6M153.8M51.9M3.75K30.4M4.87K64.6M
Accounts payable1.58M2.25M4.09M3.38M867.0K1.06M629.0K1.73M
Current liabilities14.0M8.87M7.80M16.2M10.6M10.1M111.8K9.82M75.5K8.46M
Long-term debt01.87M9.29M11.1M
Total debt9.83M6.63M1.73M2.94M09.33M14.9M14.8M
Total liabilities22.8M15.2M8.34M18.0M13.7M12.0M111.8K19.1M75.5K149.4M
Shareholders' equity196.8M125.2M148.5M181.6M140.1M39.9M-124.8M11.3M-95.3M-84.8M
Shares outstanding178.3M137.8M127.7M126.3M100.8M51.2M5.00M7.03M5.00M5.00M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY2019FY2018
Cash from operations-49.1M-44.9M-40.6M-34.1M-19.7M-26.8M-32.1K-31.7M-32.8K-33.7M
Capital spending-25.0K-44.0K-30.0K-212.0K-1.57M-106.0K-466.0K-2.02M
Free cash flow-49.2M-44.9M-40.6M-34.3M-21.2M-26.9M-32.2M-35.7M
Cash from investing-93.3M46.8M27.0M-151.2M-1.77M38.0K-466.0K-2.02M
Cash from financing129.6M17.3M2.94M75.8M118.6M48.5M31.0K37.6K37.6K64.0M
Share buybacks-15975.8M128.0M54.2M
Change in cash-12.8M19.3M-10.7M-109.6M97.2M21.8M-1.12K-32.2M4.87K28.3M